Santen Pharmaceutical Cancels Significant Treasury Shares
Company Announcements

Santen Pharmaceutical Cancels Significant Treasury Shares

Santen Pharmaceutical Co (JP:4536) has released an update.

Santen Pharmaceutical Co. has announced the cancellation of 16,985,400 treasury shares, representing 4.7% of its outstanding shares, with the action set to be completed by November 29, 2024. This strategic move is expected to leave the company with 347,036,854 outstanding shares, streamlining its share structure.

For further insights into JP:4536 stock, check out TipRanks’ Stock Analysis page.

Related Articles
TheFlyClearside Biomedical’s partner signed new collaboration agreement with Santen
TipRanks Japan Auto-Generated NewsdeskSanten Pharmaceutical Co. Reports Mixed Financial Results
TipRanks Japan Auto-Generated NewsdeskSanten Completes Strategic Share Buyback
Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App